Abstract

To explain our finding that the dimeric beta subunit of tryptophan synthase is only 50% inactivated by beta-chloro-L-alanine (Ahmed, S. A., Ruvinov, S. B., Kayastha, A. M., and Miles, E. W. (1991) J. Biol. Chem. 266, 21548-21557), we have extended our investigation using spectroscopic, steady-state kinetic, and electrophoretic methods. The spectroscopic properties of the half-active beta 2 dimer and the reactivation after alkali treatment show that the inactivation proceeds by an "enamine" mechanism. Although the fully active beta 2 dimer associates with the tryptophan synthase alpha subunit to form alpha 2 beta 2 complex, the inactive beta subunits in the half-active enzyme associate weakly or not at all with the alpha subunit. Our results provide evidence for two conformers of the beta subunit in solution: one is rapidly inactivated by beta-chloro-L-alanine and the other is not inactivated. Thermal inactivation studies and non-denaturing polyacrylamide gel electrophoresis of the half-active enzyme show that the beta 2 dimer exists in both homologous and heterologous combinations of these two forms. After removal of the reaction products and unreacted beta-chloro-L-alanine from the half-active beta 2 dimer by gel filtration, further incubation with beta-chloro-L-alanine results in the loss of 50% of the remaining activity. This result suggests that the subunits undergo rearrangement via an intermediate monomer form to regenerate the two conformers of the active beta subunit. This mechanism of rearrangement is supported by our finding that the extent of inactivation increases at lower concentrations of the beta 2 dimer.

Highlights

  • From the Laboratoryof Biochemical Pharmacology, National Institute of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health

  • We have recently shown that some mutant a2pzcomplexes of tryptophan synthase are fully inactivated by 6-chloro-Lalanine by an enamine mechanism (Scheme I) whereas the wild-type a2P2complex is not inactivated [18].The wild-type

  • We have examined the spectrum of the apo-half-active enzyme (A-I) directly by first using hydroxylamine to remove PLP from the half-active enzyme (H-I) and treating with alkali

Read more

Summary

H I XCHpCCC6

SCHEMI.EMechanisms of @-eliminationand @-replacementreactions and of mechanism-based inactivation. @-replacement reactions [1]and @-elimination reaction(s2) proceed through a series of P L P intermediates including thekey aminoacrylate intermediate I1 [6].X - is the OH- or C1- leaving group of L-serine or SCHEMI.EMechanisms of @-eliminationand @-replacementreactions and of mechanism-based inactivation. @-replacement reactions [1]and @-elimination reaction(s2) proceed through a series of P L P intermediates including thekey aminoacrylate intermediate I1 [6].X - is the OH- or C1- leaving group of L-serine or The enamine mechanism of inactivation [3]was proposed by Metzler etal. 7) Apo-@-@-inactive 8) Apo-@-@-inactivereduced 9) Holo-@-@-inactivereduced 10) 01pH010-@2 11) 01sApo-@p 12) aHolo-@-@-inactive

Method of preparation
Findings
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.